viernes, 8 de enero de 2016

Revistas con acceso abierto / Open access journals

Enero 8, 2016. No. 2200


 



Medicine
December 2015 - Volume 94 - Issue 52pp: 1-1,e1734-e2428
Journal of Neuroanaesthesiology and Critical Care
2016 Jan-April Volume 3 | Issue 1  Page Nos. 1-76
Annals of Thoracic Medicine
January-March 2016 Volume 11 | Issue 1
Page Nos. 1-87
Anaesthesia
January 2016 Volume 71, Issue 1 Pages 3-117
Anaesthesia 
Special Issue: Peri-operative Medicine
January 2016 Volume 71, Issue Supplement S1 Pages 1-77
Revista / Journal
Pediatric Anesthesia
Special Issue: Challenging Orthodoxy
January 2015 Volume 25, Issue 1 Pages 1-110
Acta Anaesthesiologica Scandinavica
January 2015 Volume 59, Issue 1 Pages 1-136
Indian Journal of Pain
January-April 2016; Vol 30, Issue 1: page 1-69
Helen Gharaei MD.Anesthesiology and Pain Management
JACCOA


          
Anestesiología y Medicina del Dolor

52 664 6848905

Copyright © 2015

5° Curso Taller de cirugía de mano /Guadalajara / enero 21-23 2016


martes, 5 de enero de 2016

RNM y sugammadex/Neuromuscular relaxants and sugammadex


Monitoreo neuromuscular, uso de relajantes musculares, y su reversión en un hospital de enseñanza de tercer nivel 2.5. años después de introducir sugammadex. Cambios de opinión y práctica clínica
Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice.
Anesthesiol Res Pract. 2015;2015:367937. doi: 10.1155/2015/367937. Epub 2015 Jan 22.
 
Parálisis residual. ¿Influencia la evolución después de cirugía ambulatoria?
Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?
Curr Anesthesiol Rep. 2014 Dec;4(4):290-302.
Abstract
Neuromuscular blocking agents are used to facilitate tracheal intubation in patients undergoing ambulatory surgery. The use of high-dose neuromuscular blocking agents to achieve muscle paralysis throughout the case carries an increased risk of residual post-operative neuromuscular blockade, which is associated with increased respiratory morbidity. Visually monitoring the train-of-four (TOF) fade is not sensitive enough to detect a TOF fade between 0.4 and 0.9. A ratio <0.9 indicates inadequate recovery. Quantitative neuromuscular transmission monitoring (e.g., acceleromyography) should be used to exclude residual neuromuscular blockade at the end of the case. Residual neuromuscular blockade needs to be reversed with neostigmine, but it's use must be guided by TOF monitoring results since deep block cannot be reversed, and neostigmine administration after complete recovery of the TOF-ratio can induce muscle weakness. The development and use of new selectively binding reversal agents (sugammadex and calabadion) warrants reevaluation of this area of clinical practice.
KEYWORDS: Ambulatory surgery; Calabadion; NMBA; Neostigmine; PORC; Residual paralysis; Respiratory complications; Sugammadex
 

          
Anestesiología y Medicina del Dolor
52 664 6848905
vwhizar@anestesia-dolor.org
anestesia-dolor.org

Copyright © 2015

Mortalidad pediátrica en anestesia/Paediatric anaesthetic-related mortalit

Revisión de mortalidad pediátrica relacionada con anestesia. Eventos adversos severos y incidentes críticos
A review of paediatric anaesthetic-related mortality, serious adverse events and critical incidents
Larissa Cronje
South Afr J Anaesth Analg 2015; DOI: 10.1080/22201181.2015.1119503
Abstract
Anaesthetists increasingly face questions from parents on the long-term outcomes of anaesthesia, and yet more immediate anaesthetic risks are not understood, nor explained to families. This review focused on paediatric anaesthetic-related mortality, cardiac arrest and anaesthetic-related serious adverse events and critical incidents during general anaesthesia, and within 24 hours of anaesthesia ending. Anaesthetic-related mortality is rare in the developed world, and is approximately 1 per 10 000 anaesthetics, but increases in high-risk children. Serious anaesthetic-related adverse events occur in 1.4 per 1 000 anaesthetics in the developed world. Data are lacking from the developing world but anaesthetic mortality is 2-3 times higher in middle-income countries and may be up to 100-fold greater in low-income countries. A critical incident occurs in 3-8% of anaesthetics and this figure is double that in low-income countries. Anaesthetic-related events are predominantly preventable. Brief recommendations on preventative strategies are made and research goals outlined.
 
          
Anestesiología y Medicina del Dolor
52 664 6848905
vwhizar@anestesia-dolor.org
anestesia-dolor.org

Copyright © 2015

Dolor neonatal


Dolor neonatal
Neonatal pain.
Paediatr Anaesth. 2014 Jan;24(1):39-48. doi: 10.1111/pan.12293. Epub 2013 Nov 13.
Abstract
Effective management of procedural and postoperative pain in neonates is required to minimize acute physiological and behavioral distress and may also improve acute and long-term outcomes. Painful stimuli activate nociceptive pathways, from the periphery to the cortex, in neonates and behavioral responses form the basis for validated pain assessment tools. However, there is an increasing awareness of the need to not only reduce acute behavioral responses to pain in neonates, but also to protect the developing nervous system from persistent sensitization of pain pathways and potential damaging effects of altered neural activity on central nervous system development. Analgesic requirements are influenced by age-related changes in both pharmacokinetic and pharmacodynamic response, and increasing data are available to guide safe and effective dosing with opioids and paracetamol. Regional analgesic techniques provide effective perioperative analgesia, but higher complication rates in neonates emphasize the importance of monitoring and choice of the most appropriate drug and dose. There have been significant improvements in the understanding and management of neonatal pain, but additional research evidence will further reduce the need to extrapolate data from older age groups. Translation into improved clinical care will continue to depend on an integrated approach to implementation that encompasses assessment and titration against individual response, education and training, and audit and feedback.
KEYWORDS:NICU; neonate; neurodevelopment; opioids; pain; regional analgesia
Valoración clínica del dolor en unidades de cuidados intensivos neonatales españolas
Clinical assessment of pain in Spanish Neonatal Intensive Care Units.
[Article in Spanish]
An Pediatr (Barc). 2015 Nov 6. pii: S1695-4033(15)00381-1. doi: 10.1016/j.anpedi.2015.09.019. [Epub ahead of print]
Abstract
INTRODUCTION:Clinical scales are currently the best method to assess pain in the neonate, given the impossibility of self-report in this age group. A study is designed with the aim of determining the current practices as regards the clinical assessment of pain in Spanish Neonatal Units and the factors associated with the use of clinical scales. METHODS:
A prospective longitudinal observational study was conducted. A total of 30 Units participated and 468 neonates were included. RESULTS: Only 13 Units (43.3%) had pain assessment protocols. Pain was evaluated with a scale in 78 neonates (16.7%, 95% CI; 13.1-20.1) and the mean number of pain assessments per patient and per day was 2.3 (Standard Deviation; 4.8), with a median of 0.75. Of the total number of 7,189 patient-days studied, there was at least one pain assessment in 654 (9.1%). No pain assessment was performed with a clinical scale on any patient in 20 (66.7%) Units. Among those that did, a wide variation was observed in the percentage of patients in whom pain was assessed, as well as in the scales used. The CRIES (C-Crying; R-Requires increased oxygen administration; I-Increased vital signs; E-Expression; S-Sleeplessness) scale was that used in most Units. In the multivariate analysis, only invasive mechanical ventilation was associated with receiving a pain assessment with a scale (OR 1.46, P=.042). DISCUSSION: The majority of neonates admitted into Intensive Care in Spain do not receive a pain assessment. Many units still do not routinely use clinical scales, and there is a wide variation between those that do use them. These results could serve as a basis for preparing national guidelines as regards pain in the neonate.
KEYWORDS: Analgesia; Dolor; Neonate; Neonato; Pain; Sedación; Sedation
PDF 
Dolor neonatal. ¿Es necesario evaluar el dolor por punciones transcutáneas?
María Hernández-Trejo, Bernarda Sánchez-Jiménez, Rosalba Barbosa-Ángeles
Perinatología y reproducción humana 2011                    

          
Anestesiología y Medicina del Dolor
52 664 6848905
vwhizar@anestesia-dolor.org
anestesia-dolor.org

Copyright © 2015